COMPASS Pathways plc (CMPS)

NMS – Real vaqt narxi. Valyuta: USD

9.37

-0.28 (-2.90%)

Yopilishda: May 12, 2026, 4:00 PM EDT

9.66

+0.29 (3.09%)

Bozor oldidan: May 13, 2026, 6:25 AM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

COMPASS Pathways plc (CMPS)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

COMPASS Pathways plc (CMPS)

Compass Pathways to Announce First Quarter 2026 Financial Results on May 13, 2026

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

These 3 Psychedelic Stocks Activated After Trump's Executive Order

Is COMPASS Pathways (CMPS) Outperforming Other Medical Stocks This Year?

Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher

What Makes COMPASS Pathways PLC Sponsored ADR (CMPS) a Strong Momentum Stock: Buy Now?

How Much Upside is Left in COMPASS Pathways (CMPS)? Wall Street Analysts Think 136%

Videolar

No Data

Press-relizlar

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher

Compass Pathways Collaborates with Osmind to Advance Independent Clinic Readiness for Psychedelic Treatments

Compass Pathways to Participate in Needham Virtual Psychedelics Forum on April 27, 2026

Search stocks

COMPASS Pathways plc (CMPS)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

COMPASS Pathways plc (CMPS)

Compass Pathways to Announce First Quarter 2026 Financial Results on May 13, 2026

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

These 3 Psychedelic Stocks Activated After Trump's Executive Order

Is COMPASS Pathways (CMPS) Outperforming Other Medical Stocks This Year?

Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher

What Makes COMPASS Pathways PLC Sponsored ADR (CMPS) a Strong Momentum Stock: Buy Now?

How Much Upside is Left in COMPASS Pathways (CMPS)? Wall Street Analysts Think 136%

Videolar

No Data

Press-relizlar

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher

Compass Pathways Collaborates with Osmind to Advance Independent Clinic Readiness for Psychedelic Treatments

Compass Pathways to Participate in Needham Virtual Psychedelics Forum on April 27, 2026